Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534
Abstract The nuclear receptor retinoid-related orphan receptor gamma t (RORγt) plays a critical role in driving Th17 cell differentiation and expansion, as well as IL-17 production in innate and adaptive immune cells. The IL-23/IL-17 axis is implicated in several autoimmune and inflammatory diseases...
Enregistré dans:
Auteurs principaux: | Xiaohua Xue, Aimee De Leon-Tabaldo, Rosa Luna-Roman, Glenda Castro, Michael Albers, Freddy Schoetens, Samuel DePrimo, Damayanthi Devineni, Thomas Wilde, Steve Goldberg, Thomas Hoffmann, Anne M. Fourie, Robin L. Thurmond |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b41726b0e6ed4617b45bd45046be2ee9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
ROR1 and ROR2 expression in pancreatic cancer
par: Dongli Liu, et autres
Publié: (2021) -
RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype
par: Demin Cai, et autres
Publié: (2019) -
Sumoylation of RORγt regulates TH17 differentiation and thymocyte development
par: Zhiheng He, et autres
Publié: (2018) -
Spotlight on Amivantamab (JNJ-61186372) for EGFR Exon 20 Insertions Positive Non-Small Cell Lung Cancer
par: Brazel D, et autres
Publié: (2021) -
NFAT primes the human RORC locus for RORγt expression in CD4+ T cells
par: Hanane Yahia-Cherbal, et autres
Publié: (2019)